BackAlamar Biosciences Overview

Alamar Biosciences Receivables

Track Alamar Biosciences's receivables ($20M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$20.34M

Peer trimmed avg / median

Loading

Alamar Biosciences Receivables History

Loading

Alamar Biosciences vs. peers: Receivables Comparison

Loading

Alamar Biosciences Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Alamar Biosciences (ALMR) FAQ

As of the most recent data (June 2026), ALMR shows a receivables of $20M. Scroll down for historical charts and peer comparison views.

Tracking ALMR's receivables over time shows whether Alamar Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $20M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Alamar Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $20M) with ownership activity and broader fundamentals.

Alamar Biosciences's receivables is $20M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.